Tenet Healthcare stock hits 52-week high at $204.87

Published 03/10/2025, 14:44
Tenet Healthcare stock hits 52-week high at $204.87

Tenet Healthcare Corporation’s stock reached a notable milestone, hitting a 52-week high at $204.87. The healthcare provider, now valued at $18 billion, maintains a "GREAT" financial health score according to InvestingPro analysis. This achievement underscores a significant upward trend for the company, which has experienced a 30.27% increase over the past year. The healthcare giant’s performance reflects its robust market position and investor confidence, with 17 analysts recently revising earnings estimates upward. However, technical indicators suggest the stock is currently overbought. As the stock climbs to new heights, Tenet Healthcare continues to capture the attention of market analysts and investors alike, marking a period of sustained financial health and strategic advancement. Discover more detailed insights and 12 additional ProTips with an InvestingPro subscription.

In other recent news, Tenet Healthcare’s financial outlook has been a focal point for analysts. RBC Capital has raised its price target for Tenet Healthcare to $230 from $189, maintaining an Outperform rating due to the company’s strong growth potential and improved capital structure. Meanwhile, Cantor Fitzgerald has reiterated its Overweight rating with a $190 price target, despite some concerns over potential Affordable Care Act (ACA) marketplace challenges and uncertainties surrounding 2026 Marketplace rates. The investment firm highlights the impact of premium increases on Health Insurance Exchange enrollment, which constitutes about 5% of Tenet Healthcare’s revenue. Cantor Fitzgerald also noted an elevated physician bonus trend in the third quarter of 2025, aligning with industry peers. Despite these challenges, Cantor Fitzgerald maintains its positive stance on Tenet Healthcare, although it remains cautious about the 2026 marketplace environment. Additionally, the company’s recent conference call did not provide the expected signals of strength for 2026, according to Cantor Fitzgerald. RBC Capital continues to view Tenet Healthcare as a top pick in the hospital sector, citing its valuation discount compared to HCA Healthcare.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.